Atlas Trials

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Clinical trial NCT02996773 · COMPLETED

Trial details

NCT number
NCT02996773
Sponsor
University of Arizona
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous LeukemiaLymphoma,Non-HodgkinLymphoma, HodgkinLymphoma, FollicularMarginal Zone LymphomaLarge Cell LymphomaMantle-Cell LymphomaGray Zone LymphomaBurkitt Lymphoma
Start date
2016-11-29
Primary completion
2025-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.